MDLN SEC Filings
SEC filings for MDLN. Annual and quarterly reports, 8-K events, Form 4 insider filings and 13D/G stake disclosures.
| Form | Filed | Accession |
|---|---|---|
| 10-KAIMedline's first post-IPO MD&A is upbeat on double-digit sales growth, Prime Vendor momentum, and a large debt paydown funded by IPO proceeds. | Feb 25, 2026 | 0002046386-26-000009EDGAR |
SEC filings for companies related to MDLN
Never miss a MDLN filing.
Get an email when MDLN files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.